GSK faces Senator probe for pulling asthma inhaler in U.S.
https://seekingalpha.com/news/4463305-gsk-faces-senator-probe-for-pulling-asthma-inhaler-in-us?source=feed_sector_healthcare
Jun 27, 2025 -
0
GSK gets FDA nod for Benlysta autoinjector in lupus
https://seekingalpha.com/news/4461636-gsk-gets-fda-nod-for-benlysta-autoinjector-in-lupus?source=feed_sector_healthcare
Jun 24, 2025 -
0
GSK’s RSV vaccine to be reviewed by the EU for expanded use in adults
https://seekingalpha.com/news/4458066-gsks-rsv-vaccine-to-be-reviewed-by-the-eu-for-expanded-use-in-adults?source=feed_sector_healthcare
Jun 13, 2025 -
0
Theravance Biopharma To Sell Remaining Interest In Trelegy Ellipta To GSK For $225 Mln, Stock Up
https://www.rttnews.com/story.aspx?Id=3543458
Jun 02, 2025 - Theravance Biopharma, Inc. (TBPH), Monday announced an agreement to sell remaining interest in net sales of Trelegy Ellipta, a chronic obstructive pulmonary disease or asthma treatment, to GSK (GSK) for $225 million in cash.
0
Spero Therapeutics, GSK Say Phase 3 PIVOT-PO Study Of Tebipenem HBr Met Primary Goal; Spero Stock Up
https://www.rttnews.com/story.aspx?Id=3542464
May 28, 2025 - Spero Therapeutics, Inc.(SPRO) and GSK plc (GSK) Wednesday reported that the pivotal Phase 3 PIVOT-PO study of tebipenem HBr in complicated urinary tract infections (cUTIs), including
pyelonephritis, met its primary goal and will stop early for efficacy. This news sent Spero stock up over 250% in pre-market activity.
0
GSK shares break six-session winning streak
https://seekingalpha.com/news/4452113-gsk-shares-break-six-session-winning-streak?source=feed_sector_healthcare
May 23, 2025 -
0
GSK wins FDA label expansion for asthma therapy Nucala in COPD
https://seekingalpha.com/news/4451737-gsk-nucala-label-expanded-fda-copd?source=feed_sector_healthcare
May 22, 2025 -
0
Notable healthcare headlines for the week: UnitedHealth, Novo Nordisk and GSK in focus
https://seekingalpha.com/news/4449655-notable-healthcare-headlines-for-the-week-unitedhealth-novo-nordisk-and-gsk-in-focus?source=feed_sector_healthcare
May 18, 2025 -
0
Pfizer, GSK RSV shot recommendations under scrutiny from RFK Jr. aide - report
https://seekingalpha.com/news/4442136-pfizer-gsk-rsv-shot-recommendations-under-scrutiny-rfk-jr-aid?source=feed_sector_healthcare
May 06, 2025 -
0
Goldman cites a “positive surprise” for GSK ahead of ACIP meeting on RSV shot
https://seekingalpha.com/news/4430966-goldman-favors-gsk-ahead-cdc-meet-rsv-shot?source=feed_sector_healthcare
Apr 14, 2025 -
0
Page 1>